The Enterprise Value as of November 2024 (TTM) for Surmodics, Inc. (SRDX) is 554.56M

According to Surmodics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 554.56M. This represents a change of 7.41% compared to the average of 516.29M of the last 4 quarters.

Surmodics, Inc. (SRDX) Historical Enterprise Value (quarterly & annually)

How has SRDX Enterprise Value performed in the past?

The mean historical Enterprise Value of Surmodics, Inc. over the last ten years is 515.33M. The current 554.56M Enterprise Value has changed 10.66% with respect to the historical average. Over the past ten years (40 quarters), SRDX's Enterprise Value was at its highest in in the September 2018 quarter at 951.10M. The Enterprise Value was at its lowest in in the March 2016 quarter at 199.77M.

Surmodics, Inc. (SRDX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Surmodics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Surmodics, Inc. (SRDX) Average Enterprise Value

How has SRDX Enterprise Value performed in the past?

The current Enterprise Value of Surmodics, Inc. (SRDX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Surmodics, Inc. (SRDX) Enterprise Value vs. Peers

How is SRDX’s Enterprise Value compared to its peers?

Surmodics, Inc.’s Enterprise Value is greater than ProSomnus, Inc. Common Stock (40.81M), less than LivaNova PLC (3.12B), greater than Electromed, Inc. (238.10M), less than OrthoPediatrics Corp. (611.40M), greater than NeuroPace, Inc. (347.61M), greater than Inogen, Inc. (137.87M), greater than Pulmonx Corporation (260.62M), greater than Apyx Medical Corporation (65.23M), less than NuVasive, Inc. (2.84B), less than CONMED Corporation (3.22B), greater than SI-BONE, Inc. (535.06M), less than AxoGen, Inc. (637.27M), greater than Anika Therapeutics, Inc. (213.70M), less than Orthofix Medical Inc. (829.81M), less than Paragon 28, Inc. (910.24M), less than Integer Holdings Corporation (5.77B), greater than Sight Sciences, Inc. (120.25M),

Build a custom stock screener for Surmodics, Inc. (SRDX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Surmodics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Surmodics, Inc. (SRDX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Surmodics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.